Alexandre Reuben

Assistant Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Immunology Immunology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Alexandre Reuben is an Assistant Professor at The University of Texas MD Anderson Cancer Center in the United States. His research focuses on immunotherapy, particularly the role of tumor-infiltrating lymphocytes and neoantigen presentation in cancer treatment. He has contributed to advancements in understanding immune infiltration in various cancers, including non-small cell lung cancer and pancreatic ductal adenocarcinoma.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Jianjun Zhang

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Hai Tran

Associate Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Jian Hu

UNITED STATES

View details

Ethan Ludmir

UNITED STATES

View details

Teresa Manzo

Assistant professor

University of Turin

ITALY

View details

Natalie Vokes

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Cara Haymaker

Assistant Professor

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Yunguan Wang

Assistant Professor

Cincinnati Children's Hospital Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Alexandre Reuben

Research Interests

Explore related searches

Contact this professor

About

Articles (18)

Phase I/II Study of the Aurora Kinase A Inhibitor Alisertib and Pembrolizumab in Refractory, Rb-Deficient Head and Neck Squamous Cell Carcinomas

Author Correction: Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy

Intratumoral neutrophil-to-lymphocyte ratio is mirrored by circulating neutrophil-to-lymphocyte ratio in non-small cell lung cancer

Clinical and Fundamental Research Progressions on Tumor-Infiltrating Lymphocytes Therapy in Cancer

Addition of Metastasis-Directed Therapy to Systemic Therapy for Oligometastatic Pancreatic Ductal Adenocarcinoma (EXTEND): A Multicenter, Randomized Phase II Trial

Assessment of human leukocyte antigen-based neoantigen presentation to determine pan-cancer response to immunotherapy

Author Correction: Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer

Single-cell and spatial proteo-transcriptomic profiling reveals immune infiltration heterogeneity associated with neuroendocrine features in small cell lung cancer

T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy

Netie: inferring the evolution of neoantigen–T cell interactions in tumors

Single-Cell Sequencing Reveals Trajectory of Tumor-Infiltrating Lymphocyte States in Pancreatic Cancer

Shared Nearest Neighbors Approach and Interactive Browser for Network Analysis of a Comprehensive Non–Small-Cell Lung Cancer Data Set

The histologic phenotype of lung cancers is associated with transcriptomic features rather than genomic characteristics

Author Correction: Multi-region exome sequencing reveals genomic evolution from preneoplasia to lung adenocarcinoma

Intertumoral Genetic Heterogeneity Generates Distinct Tumor Microenvironments in a Novel Murine Synchronous Melanoma Model

Neoadjuvant nivolumab or nivolumab plus ipilimumab in operable non-small cell lung cancer: the phase 2 randomized NEOSTAR trial

Evolution of DNA methylome from precancerous lesions to invasive lung adenocarcinomas

Short-term treatment with multi-drug regimens combining BRAF/MEK-targeted therapy and immunotherapy results in durable responses in Braf-mutated melanoma

Collaborators (8)

Jianjun Zhang

Hai Tran

Jian Hu

Ethan Ludmir

Teresa Manzo

Natalie Vokes

Cara Haymaker

Yunguan Wang

Make your next move.